Lipigon Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
IPO
- Latest Deal Amount
-
$6.59M
- Investors
-
4
Lipigon Pharmaceuticals General Information
Description
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.
Contact Information
Website
www.lipigon.seCorporate Office
- Tvistevägen 48 C
- 907 36 Umeaa
- Sweden
Corporate Office
- Tvistevägen 48 C
- 907 36 Umeaa
- Sweden
Lipigon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 01-Mar-2021 | $6.59M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Later Stage VC | 30-Jun-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 11-Feb-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 31-Dec-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 20-Dec-2016 | $163K | $163K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2010 | Completed | Startup |
Lipigon Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 13,144 | $25.27 | $25.27 | 1x | $25.27 | 2.46% | ||
| Ordinary | 21,202 | $7.62 | $7.62 | 1x | $7.62 | 3.98% |
Lipigon Pharmaceuticals Signals
Lipigon Pharmaceuticals Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Almi Invest | Venture Capital | Minority | ||
| Fort Knox | Family Office | Minority | ||
| Umeå University | University | |||
| Umeå Biotech Incubator | Accelerator/Incubator | Minority |
Lipigon Pharmaceuticals Investments (3)
Lipigon Pharmaceuticals’s most recent deal was a PIPE with Larkberget for . The deal was made on 16-Sep-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Larkberget | 16-Sep-2020 | PIPE | Private Equity | ||
| Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) | 23-Mar-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Larkberget | 24-Oct-2019 | PIPE | Private Equity |
Lipigon Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Lipigon Pharmaceuticals FAQs
-
When was Lipigon Pharmaceuticals founded?
Lipigon Pharmaceuticals was founded in 2010.
-
Where is Lipigon Pharmaceuticals headquartered?
Lipigon Pharmaceuticals is headquartered in Umeaa, Sweden.
-
What is the size of Lipigon Pharmaceuticals?
Lipigon Pharmaceuticals has 5 total employees.
-
What industry is Lipigon Pharmaceuticals in?
Lipigon Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Lipigon Pharmaceuticals a private or public company?
Lipigon Pharmaceuticals is a Private company.
-
What is the current valuation of Lipigon Pharmaceuticals?
The current valuation of Lipigon Pharmaceuticals is .
-
What is Lipigon Pharmaceuticals’s current revenue?
The current revenue for Lipigon Pharmaceuticals is .
-
How much funding has Lipigon Pharmaceuticals raised over time?
Lipigon Pharmaceuticals has raised $10.1M.
-
Who are Lipigon Pharmaceuticals’s investors?
Almi Invest, Fort Knox, Umeå University, and Umeå Biotech Incubator have invested in Lipigon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process